SCD
The enzyme stearoyl-CoA desaturase (SCD; EC 1.14.99.5), a delta-9 desaturase, responsible for the synthesis of monounsaturated fatty acids (MUFA) has been shown to be a significant player in mouse metabolism. SCD is bound to the endoplasmic reticulum (ER), a major membrane constituent of eukaryotic cells. It is associated with the multicomponent electron transport chain in liver microsomes. Membrane bound desaturases are proposed to consist of four membrane spanning domains with the N and C termini (as well as the catalytic site) being orientated toward the cytosolic side of the membrane. MUFAs are synthesised via an aerobic process from saturated fatty acyl precursors by a three-component enzyme system involving flavoproteinNADH-dependent cytochrome b5 reductase, cytochrome b5, and SCD. Sterol responsive element binding protein-1c (SREBP-1c) appears to play an important role in the transcriptional regulation of SCD.
Transcriptional activation of genes containing a sterol responsive element (SRE) are known to be under the regulation of sterols through modulation of proteolytic maturation of SREBP-1 and SREBP-2. SREBPs are in the ER membrane of a wide variety of tissues and SREBP-1c preferentially enhances the transcription of genes essential for fatty acid synthesis in the liver, including SCD1, whilst SREBP-2 activates genes involved in cholesterol biosynthesis. SREBP-1c is positively regulated by insulin at the transcriptional level and it is up-regulated in mouse models of hyperinsulinemia and down-regulated in models with insulindeficiency, such as fasting and streptozotocin-induced diabetes. SREBP-1c deficient models have a decreased hepatic SCD1 mRNA expression whilst mice expressing a constitutively active form have increased expression. SCD1 may also be regulated by factors that influence its stability or degradation. ATPase p97 is a protein involved in the regulation of proteasome-dependent degradation of SCD1. It has been reported that ATPase p97 mRNA expression in visceral and subcutaneous adipose tissue is similar between control and morbidly obese subjects. The mRNA expression of ATPase p97 appears to be depot specific with significantly higher expression being reported in visceral compared to subcutaneous adipose tissue.
References
1.Hodson L,et al. Prog Lipid Res. 2013;52(1):15–42.
Transcriptional activation of genes containing a sterol responsive element (SRE) are known to be under the regulation of sterols through modulation of proteolytic maturation of SREBP-1 and SREBP-2. SREBPs are in the ER membrane of a wide variety of tissues and SREBP-1c preferentially enhances the transcription of genes essential for fatty acid synthesis in the liver, including SCD1, whilst SREBP-2 activates genes involved in cholesterol biosynthesis. SREBP-1c is positively regulated by insulin at the transcriptional level and it is up-regulated in mouse models of hyperinsulinemia and down-regulated in models with insulindeficiency, such as fasting and streptozotocin-induced diabetes. SREBP-1c deficient models have a decreased hepatic SCD1 mRNA expression whilst mice expressing a constitutively active form have increased expression. SCD1 may also be regulated by factors that influence its stability or degradation. ATPase p97 is a protein involved in the regulation of proteasome-dependent degradation of SCD1. It has been reported that ATPase p97 mRNA expression in visceral and subcutaneous adipose tissue is similar between control and morbidly obese subjects. The mRNA expression of ATPase p97 appears to be depot specific with significantly higher expression being reported in visceral compared to subcutaneous adipose tissue.
References
1.Hodson L,et al. Prog Lipid Res. 2013;52(1):15–42.
Metabolic Enzyme/Protease
11β-HSD(15)
15-PGDH(1)
ACC(10)
ACE(15)
AChE(47)
Adenylate Cyclase(12)
ALDH(14)
Aldose Reductase(5)
Aminopeptidase(19)
BACE(19)
Casein Kinase(51)
CAT(5)
Cathepsin(9)
CETP(13)
COMT(2)
CPG2(1)
CYPs(6)
Decarboxylase(3)
Dehydrogenase(131)
DGAT(4)
Dopamine beta-hydroxylase(2)
DPP(32)
Elastase(6)
FAAH(28)
Factor Xa(31)
Fatty Acid Synthase(17)
Ftase(2)
FXR(26)
Glucokinase(1)
GSNOR(2)
Guanylate Cyclase(13)
HMGCR(17)
IDH(7)
IDO(20)
IMPDH(2)
LDH(2)
LDL(8)
Lipase(17)
Lipid(12)
MAGL(6)
MAO(72)
MMP(78)
NAMPT(12)
Neprilysin(7)
Other Targets(10)
P450(112)
PAI-1(9)
Phosphatase(95)
Phospholipase(65)
PPAR(115)
Protein Phosphatase/PTP(6)
Renin(8)
Retinoid Receptor(37)
SCD(6)
Steroid Sulfatase (STS)(2)
Thioredoxin(1)
TPH(5)
Transferase(37)
Vitamin(44)
Xanthine Oxidase (XAO)(11)
SCD
-
YTX-465
产品货号 : M28861
cas no: 2225824-53-1
YTX-465 是硬脂酰辅酶 A 去饱和酶 (IC50s = 39 nM) 和 Ole1 (IC50s = 30.4 μM) 的抑制剂。 -
SLC13A5-IN-1
产品货号 : M26450
cas no: 2227548-95-8
SLC13A5-IN-1是柠檬酸钠协同转运蛋白(SLC13A5)的选择性抑制剂,完全阻断14C-柠檬酸盐的摄取(HepG2细胞中IC50:0.022 μM)。 -
CVT-12012
产品货号 : M20507
cas no: 1018675-35-8
CVT-12012 是一种口服生物可利用的硬脂酰辅酶A去饱和酶抑制剂(SCD;在 HepG2 细胞中 IC50 = 6.1 nM)。 -
SCD1 inhibitor-1
产品货号 : M19389
cas no: 1069094-65-0
SCD1抑制剂-1是一种有效的肝脏选择性硬脂酰辅酶A去饱和酶-1 (SCD1)抑制剂。 -
MK-8245 trifluoroacetate
产品货号 : M11723
cas no: 1415559-41-9
MK-8245 三氟乙酸酯是一种有效的、选择性的肝靶向硬脂酰辅酶A去饱和酶 (SCD) 抑制剂,对大鼠、小鼠和人 SCD1 酶的 IC50 分别为 3、3 和 1 nM。